- Home
- EP vs AARD Comparison
EP vs AARD Comparison
Compare EP & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- AARD
- Stock Information
- Founded
- EP 1983
- AARD 2017
- Country
- EP United States
- AARD United States
- Employees
- EP N/A
- AARD N/A
- Industry
- EP Oil & Gas Production
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- EP Energy
- AARD Health Care
- Exchange
- EP Nasdaq
- AARD Nasdaq
- Market Cap
- EP 171.5M
- AARD 186.3M
- IPO Year
- EP N/A
- AARD 2025
- Fundamental
- Price
- EP $4.11
- AARD $10.32
- Analyst Decision
- EP
- AARD Strong Buy
- Analyst Count
- EP 0
- AARD 5
- Target Price
- EP N/A
- AARD $32.60
- AVG Volume (30 Days)
- EP 23.3K
- AARD 182.3K
- Earning Date
- EP 11-13-2025
- AARD 11-14-2025
- Dividend Yield
- EP N/A
- AARD N/A
- EPS Growth
- EP N/A
- AARD N/A
- EPS
- EP N/A
- AARD N/A
- Revenue
- EP $39,170,178.00
- AARD N/A
- Revenue This Year
- EP N/A
- AARD N/A
- Revenue Next Year
- EP N/A
- AARD N/A
- P/E Ratio
- EP N/A
- AARD N/A
- Revenue Growth
- EP N/A
- AARD N/A
- 52 Week Low
- EP $3.76
- AARD $4.88
- 52 Week High
- EP $8.12
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- EP 48.44
- AARD N/A
- Support Level
- EP N/A
- AARD N/A
- Resistance Level
- EP $4.41
- AARD N/A
- Average True Range (ATR)
- EP 0.31
- AARD 0.00
- MACD
- EP -0.24
- AARD 0.00
- Stochastic Oscillator
- EP 75.56
- AARD 0.00
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.